期刊文献+

血浆置换对药物性肝衰竭治疗效果分析 被引量:3

Effect analysis of plasma exchange on patients with drug induced liver failure
下载PDF
导出
摘要 目的观察血浆置换治疗对药物性肝衰竭的疗效。方法治疗组28例患者在内科综合治疗的基础上联合血浆置换治疗。对照组30例仅给予内科综合治疗。结果治疗组好转率为82.1%(23/28)),平均住院为28d,对照组好转率为53.3%(16/30),平均住院日为41d。治疗组患者并发症如肝性脑病,中毒性鼓肠明显改善;治疗组治疗前后血清总胆红素别为(586±188)μmol/L和(212±96)μmol/L,血氨分别为(57±12)μmol/L和(39±19)μmol/L,凝血酶原活动度分别为(32±4)%和(72±18)%,对照组治疗前后血总胆红素,血氨,凝血酶原活动度的改善不如治疗组明显,两组相比,差异有统计学意义(P<0.05)。结论在内科治疗的基础上联合血浆置换治疗可明显提高药物性肝衰竭的疗效。 Objective To assess the effect of the plasma exchange (PE) in drug induced liver failure. Methods 28 patients with drug-induced liver failure were treated with plasma exchange besides medical treatment. 30 patients as control group were given medical treatment only. Resuits The cure rate was 82.3%(23/28) in the therapeutic group and 53.3%(16/30) in the control group respectively.The hospitalization time were 28 days in the therapeutic group and 41 days in the control group.The clinical symptoms (such as hepatic encephalopathy and toxic enteroparalysis) and the laboratory data(serum total bilirubin, blood ammonia and prothrombin activity) of the therapeutic group was obviously improved compared with those of the control group (P〈0.05). Conclusion PE can improve the efficacy of therapy for drug induced liver failure.
出处 《药品评价》 CAS 2007年第6期405-407,共3页 Drug Evaluation
关键词 肝功能衰竭 药物毒性 血浆置换 Liver Failure Drug Toxicty Plasma Exchange
  • 相关文献

参考文献2

二级参考文献6

  • 1Farrell GC. Drug induced hepatic injury. J Gastroenterol, 1997, 12:3242. 被引量:1
  • 2Maria VA, Victorino RM. Development and validation of a clinicai scale for the diagnosis of drug-induced hepatitis. Hepatology, 1997, 26:664-669. 被引量:1
  • 3Benichou C. Criteria of drug-induced liver disorders. J Hepatol, 1990, 11:272. 被引量:1
  • 4Bissel DM, Gores GJ, Laskin DL, et al. Drug-induced liver injury:mechanisms and test systems. Hepatology, 2001, 33:1009-1013. 被引量:1
  • 5Lee WM. Assessing causality in drug-induced liver injury. J Hepatol, 2000,33:1003-1009. 被引量:1
  • 6陈世耀,蒋晓渠,刘天舒,王吉耀.药物性肝病的病因和临床表现[J].中华肝脏病杂志,2000,8(4):244-244. 被引量:88

共引文献39

同被引文献48

  • 1黎明,吴锦瑜.人工肝血浆置换术治疗药物性肝衰竭疗效分析[J].南方医科大学学报,2009,29(7):1499-1500. 被引量:10
  • 2刘志红,江建宁,罗光汉,吴健林.非生物型人工肝治疗急性肝衰竭的临床研究[J].广西医科大学学报,2010,27(6):873-874. 被引量:3
  • 3尚佳,徐芸,杨玉秀,贾百灵,张和平,靳秀,陈萍.人工肝支持系统治疗药物性肝损伤32例[J].中华肝脏病杂志,2005,13(11):836-838. 被引量:7
  • 4张晶,段钟平,何金秋,张伦理,陈士彬,邹春毅,辛绍杰,武文芳,马斌荣,陈煜,孔明,刘梅,韩大康.人工肝治疗对重型肝病患者生存期的影响[J].中华肝脏病杂志,2006,14(9):647-651. 被引量:59
  • 5Liver Failure and Artficial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association.肝衰竭诊疗指南[J].实用肝脏病杂志,2006,9(6):321-324. 被引量:188
  • 6Joseph S,Jeffrey LW,Anand P.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis:The Sixth Special Issue.Journal of Clinical Apheresis,2013,7(28):145-284. 被引量:1
  • 7Yu JW,Sun LJ,Zhao YH,et al.Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.Hepatology,2008,26(23):1242-1249. 被引量:1
  • 8Mao W,Ye B,Lin S,et al.Prediction value of model for end-stage liver disease scoring system on prognosis in the acute on chronic liver failure patients with plasma exchange treatment.Asaio J,2010,56(5):475-478. 被引量:1
  • 9Nakae H,Yonekawa T,Narita K,et al.Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure? .Res Commun Mol Pathol Pharmacol,2001,109(1-2):65-72. 被引量:1
  • 10Sadahiro T,Hirasawa H,Oda S,et al.Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure .Crit Care Med,2001,29(7):1386-1392. 被引量:1

引证文献3

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部